These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

255 related articles for article (PubMed ID: 36180876)

  • 1. LAG3 blockade coordinates with microwave ablation to promote CD8
    Shao D; Chen Y; Huang H; Liu Y; Chen J; Zhu D; Zheng X; Chen L; Jiang J
    J Transl Med; 2022 Sep; 20(1):433. PubMed ID: 36180876
    [TBL] [Abstract][Full Text] [Related]  

  • 2. TIGIT Blockade Exerts Synergistic Effects on Microwave Ablation Against Cancer.
    Chen Y; Huang H; Li Y; Xiao W; Liu Y; Chen R; Zhu Y; Zheng X; Wu C; Chen L
    Front Immunol; 2022; 13():832230. PubMed ID: 35320940
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Enhanced abscopal anti-tumor response via a triple combination of thermal ablation, IL-21, and PD-1 inhibition therapy.
    Wu S; Jiang H; Fang Z; Wu Y; Jiao J; Fang W; Wu Y; Lang Y; Chen N; Zhong Z; Chen L; Zheng X; Lu B; Jiang J
    Cancer Immunol Immunother; 2024 Jun; 73(8):138. PubMed ID: 38833177
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Combined use of microwave ablation and cell immunotherapy induces nonspecific immunity of hepatocellular carcinoma model mice.
    Duan X; Wang M; Han X; Ren J; Huang G; Ju S; Zhang Q
    Cell Cycle; 2020 Dec; 19(24):3595-3607. PubMed ID: 33283623
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Microwave ablation induces Th1-type immune response with activation of ICOS pathway in early-stage breast cancer.
    Zhou W; Yu M; Pan H; Qiu W; Wang H; Qian M; Che N; Zhang K; Mao X; Li L; Wang R; Xie H; Ling L; Zhao Y; Liu X; Wang C; Ding Q; Wang S
    J Immunother Cancer; 2021 Apr; 9(4):. PubMed ID: 33795388
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Enhanced antitumor efficacy through microwave ablation in combination with immune checkpoints blockade in breast cancer: A pre-clinical study in a murine model.
    Zhu J; Yu M; Chen L; Kong P; Li L; Ma G; Ge H; Cui Y; Li Z; Pan H; Xie H; Zhou W; Wang S
    Diagn Interv Imaging; 2018 Mar; 99(3):135-142. PubMed ID: 29398572
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Enhanced antitumor efficacy through microwave ablation combined with a dendritic cell-derived exosome vaccine in hepatocellular carcinoma.
    Zhong X; Zhou Y; Cao Y; Ding J; Wang P; Luo Y; Liu H; Zhu Z; Jing X
    Int J Hyperthermia; 2020; 37(1):1210-1218. PubMed ID: 33100037
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Microwave ablation combined with PD-L1 blockade synergistically promotes Cxcl9-mediated antitumor immunity.
    He N; Huang H; Wu S; Ji W; Tai Y; Gao R; Liu Y; Liu Y; Chen L; Zhu D; Zheng X; Jiang J
    Cancer Sci; 2024 Jul; 115(7):2196-2208. PubMed ID: 38655660
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cordycepin synergizes with CTLA-4 blockade to remodel the tumor microenvironment for enhanced cancer immunotherapy.
    Chen L; Zheng X; Huang H; Feng C; Wu S; Chen R; Jiang H; Yuan M; Fu Y; Ying H; Zhou J; Jiang J
    Int Immunopharmacol; 2023 Nov; 124(Pt A):110786. PubMed ID: 37611443
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Microwave ablation combined with anti-PD-1/CTLA-4 therapy induces an antitumor immune response to renal cell carcinoma in a murine model.
    Guo RQ; Peng JZ; Li YM; Li XG
    Cell Cycle; 2023 Jan; 22(2):242-254. PubMed ID: 35980140
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Preoperative single-dose camrelizumab and/or microwave ablation in women with early-stage breast cancer: A window-of-opportunity trial.
    Pan H; Yu M; Tang X; Mao X; Liu M; Zhang K; Qian C; Wang J; Xie H; Qiu W; Ding Q; Wang S; Zhou W
    Med; 2024 Apr; 5(4):291-310.e5. PubMed ID: 38417440
    [TBL] [Abstract][Full Text] [Related]  

  • 12. CD226 identifies functional CD8
    Huang H; Huang Z; Ge J; Yang J; Chen J; Xu B; Wu S; Zheng X; Chen L; Zhang X; Jiang J
    Front Immunol; 2023; 14():1150803. PubMed ID: 37056782
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Single-cell RNA sequencing reveals compartmental remodeling of tumor-infiltrating immune cells induced by anti-CD47 targeting in pancreatic cancer.
    Pan Y; Lu F; Fei Q; Yu X; Xiong P; Yu X; Dang Y; Hou Z; Lin W; Lin X; Zhang Z; Pan M; Huang H
    J Hematol Oncol; 2019 Nov; 12(1):124. PubMed ID: 31771616
    [TBL] [Abstract][Full Text] [Related]  

  • 14. LAG3 and TIGIT Expression on Tumor-Infiltrating Lymphocytes in Cutaneous Melanoma.
    Naimy S; Bzorek M; Eriksen JO; Løvendorf MB; Litman T; Dyring-Andersen B; Gjerdrum LMR
    Dermatology; 2024; 240(1):156-163. PubMed ID: 37952520
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Microwave ablation combined with OK-432 induces Th1-type response and specific antitumor immunity in a murine model of breast cancer.
    Li L; Wang W; Pan H; Ma G; Shi X; Xie H; Liu X; Ding Q; Zhou W; Wang S
    J Transl Med; 2017 Jan; 15(1):23. PubMed ID: 28137271
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Distinct exhaustion features of T lymphocytes shape the tumor-immune microenvironment with therapeutic implication in patients with non-small-cell lung cancer.
    Kim CG; Kim G; Kim KH; Park S; Shin S; Yeo D; Shim HS; Yoon HI; Park SY; Ha SJ; Kim HR
    J Immunother Cancer; 2021 Dec; 9(12):. PubMed ID: 34907028
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Single-cell RNA sequencing reveals the effects of anti-PD-L1 therapy on 3LL lung cancer model and its tumor microenvironment.
    Zhang H; Huang H; Wu S; He X; Chen J; Zheng X; Chen L; Wang Z
    Med Oncol; 2023 Aug; 40(10):285. PubMed ID: 37653265
    [TBL] [Abstract][Full Text] [Related]  

  • 18. TIGIT and PD1 Co-blockade Restores ex vivo Functions of Human Tumor-Infiltrating CD8
    Ge Z; Zhou G; Campos Carrascosa L; Gausvik E; Boor PPC; Noordam L; Doukas M; Polak WG; Terkivatan T; Pan Q; Takkenberg RB; Verheij J; Erdmann JI; IJzermans JNM; Peppelenbosch MP; Kraan J; Kwekkeboom J; Sprengers D
    Cell Mol Gastroenterol Hepatol; 2021; 12(2):443-464. PubMed ID: 33781741
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The CXCL10/CXCR3 Pathway Contributes to the Synergy of Thermal Ablation and PD-1 Blockade Therapy against Tumors.
    Xiao W; Huang H; Zheng P; Liu Y; Chen Y; Chen J; Zheng X; Chen L; Jiang J
    Cancers (Basel); 2023 Feb; 15(5):. PubMed ID: 36900218
    [TBL] [Abstract][Full Text] [Related]  

  • 20. CC-01 (chidamide plus celecoxib) modifies the tumor immune microenvironment and reduces tumor progression combined with immune checkpoint inhibitor.
    Chen JS; Chou CH; Wu YH; Yang MH; Chu SH; Chao YS; Chen CN
    Sci Rep; 2022 Jan; 12(1):1100. PubMed ID: 35058524
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.